Last update 21 May 2025

OL-108

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
OL 108, OL108
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesNervous System DiseasesCardiovascular Diseases+ [4]
Active Indication
Granulomatosis With PolyangiitisIdiopathic Inflammatory MyopathiesLupus Nephritis+ [3]
Inactive Indication-
Originator Organization
Allogene Overland Therapeutics (PRC) Co., Ltd.
Active Organization
Allogene Overland Biopharm (Shanghai) Co., LtdBeijing Gaobo Hospital Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with OL-108
NCT06980597
/ RecruitingPhase 1
An Open-Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Allogeneic CAR-T Cell Therapy (OL-108) in the Treatment of Relapsed/Refractory Autoimmune Diseases
100 Clinical Results associated with OL-108
Login to view more data
100 Translational Medicine associated with OL-108
Login to view more data
100 Patents (Medical) associated with OL-108
Login to view more data
100 Deals associated with OL-108
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Granulomatosis With PolyangiitisPhase 1
China
Beijing Gaobo Hospital Co., Ltd.
01 Jun 2025
Idiopathic Inflammatory MyopathiesPhase 1
China
Beijing Gaobo Hospital Co., Ltd.
01 Jun 2025
Lupus NephritisPhase 1
China
Beijing Gaobo Hospital Co., Ltd.
01 Jun 2025
Microscopic PolyangiitisPhase 1
China
Beijing Gaobo Hospital Co., Ltd.
01 Jun 2025
Scleroderma, SystemicPhase 1
China
Beijing Gaobo Hospital Co., Ltd.
01 Jun 2025
Autoimmune DiseasesPreclinical
China
Allogene Overland Biopharm (Shanghai) Co., Ltd
01 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free